Abstract The value of a diagnostic test lies in its ability to detect patients with disease (its sensitivity) and to exclude patients without disease (its specificity). For tests with binary outcomes, these measures are fixed. For tests with a continuous scale of values, various cutoff points can be selected to adjust the sensitivity and specificity of the test to conform with W HEN a doctor orders a test, he has, on the basis of his knowledge and experience, a certain impression of its reliability. Does the test have many falsely positive or negative results? Moreover, whatever the result, will the Hndings playa determining part in shaping the doctor's decision, or will they affect his diagnosis only in a minor and complementary way? The answer to such questions need not depend merely on impression. A number of critical methods are available to evaluate diagnostic (or, for that matter, therapeutic) procedures. In addition, critical evaluation is necessary so that use of given diagnostic procedures can be justified in these days of limited resources and spiralling costs for medical care.
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This primer describes three methods to achieve such critical evaluation. Though the methods go by names foreign to most physicians, their basic principles are relatively simple. In essence, they consider the ability of a diagnostic procedure to detect patients with disease while simultaneously excluding patients without disease. They also take into account goals of the physician requesting the testfor example, is he concerned primarily with health or financial cost-benefit relations, or is he concerned only with the amount of diagnostic information contained in the test? The technical terms used for the three methods to be described are the decision matrix, the receiver op-. erating characteristic (ROC) curve and information theory. Once a diagnostic procedure has been evaluated by one of these technics, simple algebraic manipulations can be performed so that the result of a test can be applied to a particular patient; a formula called Bayes's theorem is . used for this purpose. From By use of a decision matrix we can logically relate the results of a diagnostic test to the clinical or pathologic outcome. This type of analysis is most easily applied to the simple decision of whether disease is present, D +, or absent, D -, when the test is abnormal (i.e., positive), T +, or normal (i.e., negative), T -. When, as shown in Table I,  these two binary results are plotted on a two-X -two table  to show the four possible combinations (indicated by a, b, c and d), a decision matrix is formed.
Each of the four combinations can be used to evaluate the test by comparing its results to the actual presence or absence of disease (i.e., four ratios may be formed). The so-called true-positive (TP) ratio is the proportion of positive tests in all patients who actually have the disease, or _a_ . This value expresses probability (P) that patients a+b with the disease will have abnormal test results, and can be written as the "conditional probability" P(T + ID+)* -i.e., the probability that a patient with disease, D +, will have a positive test, T + . The true-positive ratio expresses the sensitivity of the examination. It measures the fraction of patients with disease that will be detected by the diagnostic test in question.
The false-positive (FP) ratio is the proportion of positive tests in all patients who do not have disease, or _c_ . It c+d is the probability that patients without disease will have abnormal test results, P(T + ID -).
The true-negative (TN) ratio is the proportion of negative tests in all patients who do not have the disease, or
. It is the probability that patients without disease c+d will have negative test results, P(T -ID -). This ratio expresses the specificity of the examination. It measures the fraction of patients who will be correctly identified as havingno disease. It is equal to (1 -FPratio). The false-negative (FN) ratio is the proportion of negative tests in all patients with disease, or~. It is the a+b probability that patients with disease will have negative test results, P(T -ID +). It is equal to (1 -TP ratio).
Obviously, a good diagnostic examination has a high TP ratio and a low FP ratio; it correctly identifies a large portion of diseased patients without incorrectly including patients without disease. The ratio of the TP ratio to the FP ratio is known as the likelihood ratio, L. Obviously, tests with high likelihood ratios are better discriminators of disease than those with low ones.
These test characteristics may be illustrated with a specificexample. In a study on the use ofliver scans for detecting disease in 344 patients, the actual state of the liver was determined either by biopsy or at autopsy. 1 When the actual numbers as determined by the scans and by the morphologic examinations are put into the decision matrix, the following table emerges ( Table 2) .
We may calculate the characteristics of the liver scan to be as follows: . tients with disease as normal versus classifying normal patients as diseased. In screening for a potentially fatal disease with a fairly safe treatment, for example, we would be likely to accept a large proportion of false-positive diagnoses to ensure that our test discovers almost all diseased patients -i.e., that it has high sensitivity. Patients with hypothyroidism fall into this category because of the high morbidity associated with failing to diagnose and treat this disease and the low morbidity associated with treating euthyroid patients with replacement therapy. For less serious conditions or more dangerous treatments, on the other hand, we are willing to miss more diseased patients to reduce the number of false-positive diagnoses.
If we select a cutoff point that makes the test very sensitive to detect as many patients with actual disease as possible, the number of false-positive diagnoses unavoidably increases; in other words, the more sensitive the examination, the less specific it becomes. To help us determine the most advantageous cutoff point, we first construct a graph plotting true-positive (TP) ratios (i.e., the expression of sensitivity) against false-positive (FP) ratios. The resulting plot, which takes the shape of a smooth, concave curve, is know as an "ROC curve" (receiver-operating-characteristic curve).
A hypothetical ROC curve was constructed ( 
General Characteristics
Few tests have simple binary outcomes and thus cannot be classified as just positive or negative. Instead, most yield a continuous scale of values, of which one of several can be selected as a cutoff point to differentiate subjects with and without disease. The cutoff point chosen depends on the relative costs associated with classifying pa- For example, on the average, if the cost of missing a diagnosis is high and the cost of mistakenly treating patients is low, intuition tells us to operate at a point near E on the ROC curve (Fig. I) where we treat all patients with disease. The formula supports this estimate because under these conditions, the ratio AC fp lAC fn is small, and the slope of the curve changes only slightly near E. On the other hand, if the therapeutic results of treating a disease are of marginal value, and the health costs of treating a patient without disease are high, intuition tells us to oper- 
Selection of a Cutoff Point
Selection of an appropriate cutoff point is aided by knowledge of the probability of disease in the patient population of interest. This probability of disease in any given member of the group as a whole is called the prior or pretest (that is, before the results of the test in the given member are obtained) probability and may be designated as P(D+). The prior or pretest probability of no disease may be designated as P(D-). For illustrative purposes in subsequent examples, we shall assume that the hypothetical test described in Table 3 Selection of an appropriate cutoff point is also aided by knowledge of the costs associated with errors in diagnosis -both false-positive and false-negative errors. We are generally interested in the additional costs associated with these errors in comparison with the costs associated with an ideal or perfect test. Costs can be divided into those that pertain to health and those that pertain to money. •. false-positive diagnoses. At this cutoff point the test has do not take into account the morbidity, pain and anxiety great specificity but very poor sensitivity. When test reassociated with the diagnostic tests and therapeutic regi-. . . . . . . suits greater than those corresponding to the value at mens. It is possible, therefore, that the morbidity associat-• point C are considered abnormal, 70 per cent of patients ed with the best treatment regimen (measured in terms of with disease are detected, but 10 per cent of subjects person-years)wouldbesufficientlyhighsothatagivenpawithout disease have abnormal results. When a low cutoff tient would prefer a less effective regimen. Ideally, physivalue (point E) is used to separate those with disease from cians should take patients' preferences regarding mortalithose without, all patients with disease are identified, but ty and morbidity into account when making decisions in at the expense of including a large proportion of patients their behalf. Some weighting of mortality and morbidity (70 per cent) without disease. The location of a cutoff should probably be performed, and the resulting index point along an ROC curve is called an "operating posicalled "healthy person-years of life" rather than persontion." years oflife alone. Financial costs have two major components. There are the medical bills themselves, paid by the patient or some third party. In addition, since death or disability may prevent patients from supporting themselves or others, there may be additional costs to society and insurers for support of patients or their dependents. Even if these support costs cannot be exactly determined, it is clear that use of medical bills alone to determine the cost of diagnosis and treatment underestimates the total financial costs.
When health costs are most important and are used to select a cutoff point between normal and abnormal results, we want to minimize differences in person-years (or, ideally, healthy person-years) between our diagnosis and treatment and that existing for perfect diagnosis and optimal treatment. If we let the additional cost in personyears associated with a false negative diagnosis be AC fn and with a false-positive diagnosis be AC fp we can determine from statistical decision theory* that the optimal operating position on the ROC curve occurs where the slope of the ROC curve equals
AC fn P(D+) *The ratio of the probability of disease to the probability of no disease, P(D+) , is known as the prior odds and is usually designated by the Greek I'(D-) letter omega, O. In this example the prior odds are 3:7. The prior probability of disease can be calculated from the prior odds by the following relation': I'(D+) =~.
1+0. ' This definition implies that one year of life for two individuals is the same as two years of life for one person and that all years of life are valued equally.
'Derivation of expression (1) ate at a posItion near point A where the slope, like AC lp fAC ln , is steep. Finally, if the likelihood of disease in the patient is very small (that is, the ratio of the probability of no disease to disease is large), we again choose a point near A; this situation occurs in screening programs. When financial costs are our criterion for selection of a cutoff point, the same principles apply except that now the additional costs relate to money. AC fp , for example, is the extra cost associated with unnecessary diagnostic and perhaps therapeutic regimens, whereas AC In is the additional cost caused by the progression of untreated disease.
In many cases we do not have accurate estimates of the additional health or financial costs associated with errors in diagnosis. One approach to this problem is to choose a cutoff point that minimizes our mistakes. This It is important to emphasize that the cutoff point chosen is best only for the measure of costs selected. Thus, if costs are based on mortality, the resulting operating position should" yield the lowest average mortality. If costs are based on finances, the lowest average financial cost results. This resulting cutoff point need not be the same as that associated with the lowest average mortality. In addition, the cutoff point that minimizes mistakes may differ from both these points.
In evaluating various therapeutic or diagnostic procedures, these health and financial costs are initially estimated independently. To relate diagnostic or treatment (health) costs to financial costs we may calculate an average financial cost required to achieve a given unit of health (e.g., person-years) for each procedure; this is an average cost. In comparing various therapeutic or diagnostic procedures, a cost called a marginal cost may be calculated. This cost is the financial cost of achieving one additional unit of health (e.g., one more person-year) by one procedure over another. For example, if one treatment costing $15,000 yields five person-years of life and another costing $8,000 yields three person-years of health, the marginal cost of each additional person-year resulting from the first treatment is $3,500 {(l5,000-8,000)f(5-3)}. For diagnostic procedures the same principles apply except that now the average cost relates to finding a patient with disease and the marginal cost relates to finding an additional patient with disease using one diagnostic procedure as compared with another. Such diagnostic procedures can be either different tests or different cutoff points applied to the results of a single test.
INFORMATION THEORY

General Characteristics
Information theory has been used as one of several posible means for selecting a cutoff point along the ROC curve. 2 In this context, information is defined as a reduction in uncertainty; thus, the greater the difference between the certainty of a diagnosis after a test is performed and the certainty before it is performed, the greater the information content of test. Accordingly, if the certainty about a given diagnosis is already high, little information is gained from an additional diagnostic test. For example, results of a serum ceruloplasmin level in a patient with Kayser-Fleischer rings and ataxia provide less information than results of a similar test in a brother of a child with Wilson's disease. In the former instance we are fairly certain of the diagnosis on the basis of physical findingsthat is, our pretest probability estimate is already close to 1.0. In the latter instance, on the other hand, we are less certain; our pretest probability is lower, around 0.25, and we therefore gain much more information from a serum ceruloplasmin measurement. Obviously, if we think that one disease is as likely to be present as not, our pretest probability is 0.50; in this case, we gain information from a test that will help us go from a completely uncertain 50:50 state to one of greater certainty.
Selection of a Cutoff Point
A theoretical relation exists between the maximum information content obtainable from a perfect test (TP ratio = 1, FP ratio = 0) and the frequency of the disease in question; this relation is described by a smooth curve having a continuous range of values (Fig. 2) . Because most tests are not perfect, however, the theoretical maximum value is seldom achieved. The actual value depends upon the TP and FP ratios. Tests that have a continuous scale of values and thus a number of possible discrete cutoff points have different amounts of information associated with each cutoff point as well as with each prior probability. For example, we can calculate* the information content for each of the cutoff points on the ROC curve presented in Figure I , and to show that for prior probabilities of 0.25, 0.50 and 0.75, the information content at point D is higher than that for points A, B, C and E. The cutoff point of a diagnostic test having a value closest to the theoretical one is the one that maximizes the information content of the test. This point is said to have an information content of I max
BAYES'S THEOREM
Once a diagnostic test has been evaluated so that its characteristics (i.e., sensitivity and specificity) are known, it is possible to formulate new probability statements about the presence or absence of disease in a particular patient examined by the diagnostic test. These probability statements are called posterior or post-test probabilities because they reflect the test results. If a patient has an abnormal test result the probability of disease is written as P(D + IT +)and if he has a normal test result, it is written as ' We calculated these results by evaluating a complex algebraic expression derived and discussed in detail by Metz. 2 This expression makes use of the TP and FP ratios of the test (or, in our case, of the ratios corresponding to varying cutoff points) and of the prior probability with which weare concerned. 
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Alternatively, if we wish to know the probability that a patient with a normal test result has disease, we need to know the TN and FN ratios as well as P(D + ) and P(D -). The relevant formula is:
. P(T-ID+)P(D+) + P(T-ID-)P(D-) Figure 2 . Information Content of a Test as a Function of the Prior Probability of Disease. The maximum information content theoretically obtainable occurs with a perfect test (TP ratio = 1, and FP ratio = 0); its maximum value is 1.0 and occurs where the prior probability is 0.5 (solid line). The circles represent the maximum information content (hnax) for the hypothetical ROC curive (Fig. 1) at three prior probabilities; these three values of Imax are associated with point D on the ROC curve.
*The Reverend Thomas Bayes (1702-1761) was the author of the first treatise on one type of inductive inference. He is believed to be responsible for the following statement written in 1736: "It is not the business of a Mathematician to show that a strait line or circle can be drawn, but he tells you what he means by these; and if you understand him, you may proceed further with him; and it would not be to the purpose to object that there is no such thing in nature as a true strait line or perfect circle, for this is none of his concern; he is not inquiring how things are in matter of fact, but supposing things to be ina certain way, what are the consequences to be deduced from them; and all that is to be demanded of him is, that his suppositions be intelligible, and his inferences just from the suppositions he makes." A negative test has reduced the probability of disease from 0.30 to 0.05, a factor of six. In this context, the test is more useful in ruling out disease than in detecting it.
The difference between posterior and prior probabilities is strongly dependent upon the true-positive and false-positive ratios for the diagnostic test. A nomogram relating both prior and posterior probabilities to these ratios has been constructed for a wide range of test sensitivities. 3 For tests that are "perfectly sensitive" (TP ratio = 1.0), a family of curves relating prior to posterior probability can be constructed for varying false-positive ratios. 4 The elementary principles enumerated in this primer have been discussed in more detail by Lusted 5 and by Barnoon and Wolfe. 6 These authors point out that these principles can be applied to a wide range of clinical problems from clinical decisions involving individual patients to matters of public-health policy. Several articles in this issue are devoted to examples of these types of analyses.
As a specific example illustrating these formulas consider the hypothetical test (Table 3 , Fig. 1 ) performed on a group of patients 30 per cent of whom are estimated to have disease. Let us assume that we have used point D as our cutoff point. The probability of disease in a patient with an abnormal test is calculated from equation (2) and is (2) . Bayes's* theorem is a technic that allows us to calculate these posterior probabilities that we wish to know from information that we already know beforehand ("a priori") about the implications of a diagnostic test. For example, if we wish to estimate the probability of disease in a patient with an abnormal test result we must know the probabilities that the diagnostic test will be positive in patients with and without disease -the TP and FP ratiosand an estimate of the prior probabilities, P(D +) and P(D-). Thefollowing formula is used: P(D+IT+) = P(T+ID+) P(D+) P(T+ID+)P(D+) + P(T+ID- l;
